Recent Finacing
Recent Raise
Innovo Therapeutics develops oncology targeted‑protein‑degradation drugs (molecular glues and PROTACs) using dual TPD discovery platforms, high‑throughput screening and compound libraries, with R&D sites in San Diego and China.
